Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Journal of Virology|June 5, 2015
Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus InfectionKevin O Saunders, Lingshu Wang, M Gordon Joyce, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
HIV broadly neutralizing antibody escapability drives the therapeutic efficacy of vectored immunotherapyNicolas M S Galvez, Yi Cao, Adam D Nitido, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2021
Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccinesVivek Naranbhai, Wilfredo F Garcia-Beltran, Christina C Chang, et al.
The Journal of Infectious Diseases|December 10, 2021
Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 VaccinesVivek Naranbhai, Wilfredo F Garcia-Beltran, Christina C Chang, et al.
Immunity|February 26, 2026
HIV broadly neutralizing antibody escape dynamics drive the outcome of AAV-vectored immunotherapy in humanized miceNicolas M S Galvez, Adam D Nitido, Seo Bin Yoo, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residentsYasin Abul, Clare Nugent, Igor Vishnepolskiy, et al.
Geroscience|October 12, 2024
Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residentsYasin Abul, Clare Nugent, Igor Vishnepolskiy, et al.
Cell Reports|April 2, 2025
Two distinct durable human class-switched memory B cell populations are induced by vaccination and infectionCory A Perugino, Hang Liu, Jared Feldman, et al.
Cell Reports|April 14, 2022
Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infectionDevin J Kenney, Aoife K O'Connell, Jacquelyn Turcinovic, et al.
Nature Medicine|April 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trialJoseph P Casazza, Evan M Cale, Sandeep Narpala, et al.
Pageof 11